| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
253,520,000 |
| Market
Cap: |
5.16(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$10.95 - $23.77 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 5.8 |
| Insider 6 Months : 5.8 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 1044 |
| Guru Rank Value : -1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Organon & Co. is a health care company, focused on improving the health of women throughout their lives. Co. develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Co. has a portfolio of medicines and products across a range of therapeutic areas. Co. sells these products through various channels including drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Co. operates manufacturing facilities located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the U.K.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,720 |
2,720 |
2,720 |
2,720 |
| Total Buy Value |
$49,939 |
$49,939 |
$49,939 |
$49,939 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fiedler Susanne |
Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$107,536 |
D/D |
(4,286) |
17,395 |
|
- |
|
| Fiedler Susanne |
Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,116 |
21,681 |
|
- |
|
| Milligan Sandra |
Head of Research & Development |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$58,861 |
D/D |
(2,346) |
20,861 |
|
- |
|
| Milligan Sandra |
Head of Research & Development |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,976 |
23,207 |
|
- |
|
| Weaver Kirke |
Gen. Counsel & Corp. Secy. |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$35,904 |
D/D |
(1,431) |
5,481 |
|
- |
|
| Weaver Kirke |
Gen. Counsel & Corp. Secy. |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,616 |
6,912 |
|
- |
|
| Ali Kevin |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
D |
$25.09 |
$160,250 |
D/D |
(6,387) |
29,919 |
|
- |
|
| Ali Kevin |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,393 |
36,306 |
|
- |
|
| Nisita Vittorio |
Head of Global Business Svcs |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$33,094 |
D/D |
(1,319) |
7,105 |
|
- |
|
| Nisita Vittorio |
Head of Global Business Svcs |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,419 |
8,424 |
|
- |
|
| Morrissey Joseph T. Jr. |
Head of Manufacturing |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$47,194 |
D/D |
(1,881) |
14,700 |
|
- |
|
| Morrissey Joseph T. Jr. |
Head of Manufacturing |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,266 |
16,581 |
|
- |
|
| Falcione Aaron |
Chief Human Resources Officer |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$47,696 |
D/D |
(1,901) |
9,787 |
|
- |
|
| Falcione Aaron |
Chief Human Resources Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,125 |
11,688 |
|
- |
|
| Ritter Geralyn S |
Head of Ext. Affairs and ESG |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$38,714 |
D/D |
(1,543) |
7,585 |
|
- |
|
| Ritter Geralyn S |
Head of Ext. Affairs and ESG |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,102 |
9,128 |
|
- |
|
| Dimarco Kathryn |
Corporate Controller |
• – – |
2023-02-09 |
4 |
D |
$29.68 |
$21,963 |
D/D |
(740) |
3,875 |
|
- |
|
| Dimarco Kathryn |
Corporate Controller |
• – – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,869 |
4,615 |
|
- |
|
| Weaver Kirke |
Gen. Counsel & Corp. Secy.Offi |
• – – |
2023-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,296 |
|
-26% |
|
| Walsh Matthew M |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
D |
$32.41 |
$349,704 |
D/D |
(10,790) |
31,706 |
|
- |
|
| Walsh Matthew M |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,343 |
42,496 |
|
- |
|
| Stahler Rachel A |
Chief Information Officer |
• – – |
2022-08-05 |
4 |
D |
$32.41 |
$143,123 |
D/D |
(4,416) |
18,950 |
|
- |
|
| Stahler Rachel A |
Chief Information Officer |
• – – |
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,890 |
23,366 |
|
- |
|
| Dimarco Kathryn |
Corporate Controller |
• – – |
2022-05-04 |
4 |
D |
$32.44 |
$13,852 |
D/D |
(427) |
2,746 |
|
- |
|
| Dimarco Kathryn |
Corporate Controller |
• – – |
2022-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,246 |
3,173 |
|
- |
|
198 Records found
|
|
Page 5 of 8 |
|
|
0.03 (0.15%) 
